Pharmacokinetic Profile and Palatability of Atomoxetine Oral Solution in Healthy Japanese Male Adults

por Nakano, Masako, Witcher, Jennifer, Satoi, Yoichi, Goto, Taro
Publicado 2016

Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

por Hazell, Philip, Becker, Katja, Nikkanen, Eija A., Trzepacz, Paula T., Tanaka, Yoko, Tabas, Linda, D’Souza, Deborah N., Witcher, Jennifer, Long, Amanda, Ponsler, George, Dittmann, Ralf W.
Publicado 2009

In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1

por Pak, Y. Anne, Long, Amanda J., Annes, William F., Witcher, Jennifer W., Knadler, Mary Pat, Ayan-Oshodi, Mosun A., Mitchell, Malcolm I., Leese, Phillip, Hillgren, Kathleen M.
Publicado 2017

Target modulation and pharmacokinetics/pharmacodynamics translation of the BTK inhibitor poseltinib for model-informed phase II dose selection

por Byun, Joo-Yun, Koh, Yi T., Jang, Sun Young, Witcher, Jennifer W., Chan, Jason R., Pustilnik, Anna, Daniels, Mark J., Kim, Young Hoon, Suh, Kwee Hyun, Linnik, Matthew D., Lee, Young-Mi
Publicado 2021

Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human

por Rorick-Kehn, Linda M., Witcher, Jennifer W., Lowe, Stephen L., Gonzales, Celedon R., Weller, Mary Ann, Bell, Robert L., Hart, John C., Need, Anne B., McKinzie, Jamie H., Statnick, Michael A., Suico, Jeffrey G., McKinzie, David L., Tauscher-Wisniewski, Sitra, Mitch, Charles H., Stoltz, Randall R., Wong, Conrad J.
Publicado 2015